PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vaccine Evaluation Center, BC Children\'s Hospital Research Institute, Vancouver, British Columbia, Canada jbettinger@bcchr.ubc.ca.\', \'Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.\', \'Vaccine Evaluation Center, BC Children\'s Hospital Research Institute, Vancouver, British Columbia, Canada.\', \'CHU de Québec-Université Laval, Quebec, Québec, Canada.\', \'Centre Intégré Universitaire de Santé et de Services Sociaux de l\'Estrie-Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada.\', \'Alberta Children\'s Hospital Research Institute, Calgary, Alberta, Canada.\', \'Pediatrics, University of Calgary, Calgary, Alberta, Canada.\', \'Medicine, Unity Health Toronto, Toronto, Ontario, Canada.\', \'University of Toronto, Toronto, Ontario, Canada.\', \'Canadian Center for Vaccinology, Dalhousie University, Halifax, Nova Scotia, Canada.\', \'Pediatrics, IWK Health Centre, Halifax, Nova Scotia, Canada.\', \'College of Pharmacy, Dalhousie University, Halifax, Nova Scotia, Canada.\', \'Sinai Health System, Toronto, Ontario, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/bmjopen-2021-051254
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 35058258
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
?:title
  • The Canadian National Vaccine Safety Network: surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all